Fonville Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Buy
294
+43
+17% +$43.9K 0.06% 111
2026
Q1
$231K Buy
251
+50
+25% +$50.7K 0.04% 127
2025
Q4
$216K Buy
+201
New +$192K 0.04% 123
2025
Q2
– Sell
-309
Closed -$255K – 124
2025
Q1
$255K Sell
309
-35
-10% -$29.1K 0.08% 105
2024
Q4
$266K Sell
344
-44
-11% -$36.4K 0.09% 95
2024
Q3
$343K Buy
+388
New +$349K 0.12% 83
2024
Q2
– Sell
-305
Closed -$237K – 99
2024
Q1
$237K Buy
+305
New +$217K 0.11% 86

Other funds holding LLY

Fonville Wealth Management's LLY Position: Q2 2026 in Review

Fonville Wealth Management increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $43.9K and bringing the position to 294 shares worth $352K. The position accounts for 0.06% of the portfolio, ranked #111.

Fonville Wealth Management first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fonville Wealth Management held 294 shares of Eli Lilly worth $352K as of Q2 2026.
  • Fonville Wealth Management bought 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.06% of Fonville Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Fonville Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fonville Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.